Advertisement

Topics

Allergan, Inc. and MAP Pharmaceuticals, Inc. Company Profile

10:57 EDT 24th June 2018 | BioPortfolio

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 10,800 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention and urologics, Allergan is proud to celebrate more than 60 years of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to: www.allergan.com.


News Articles [906 Associated News Articles listed on BioPortfolio]

Pfizer creates breaking news with Allergan purchase

US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. The takeover could allow Pfizer to escape relatively hi...

Allergan Plc Declares Ownership of Stake in Teva Pharmaceutical Industries Ltd

The investor owns 68,741,067 shares of the stock valued at about $1,517,115,349. The reporting parties listed on the disclosure included Allergan Holdings B1, Inc, Allergan WC Holding Inc, Warner Chil...

Sun Pharma, Ironwood and Allergan settle Linzess patent litigation

Sun Pharmaceutical Industries’ wholly owned subsidiaries have reached an agreement with Ironwood Pharmaceuticals and Allergan to resolve the patent litigation...Read More... The post Sun Pharma, Iro...

Quotidian Technical Highlights on Selected Generic Drugs Stocks -- Allergan, Catalyst Pharma, ...

www.wallstequities.com/registration Allergan On Wednesday, shares in Dublin, Irelandheadquartered Allergan PLC recorded a trading volume of 3.79 million shares, which was above their three months ...

The Allergan Model

Allergan is a 'restless company', according to David Pyott, its CEO, and that is what makes it an exciting and dynamic company to work for. Made famous by Botox, Allergan's roots are firmly in ophthal...

Allergan and Ironwood Settle Linzess Patent Suit With Sun Pharma

NewsWith the settlement, Ironwood and Allergan will grant the wholly owned subsidiaries of Sun Pharma a license to market a generic version of Linzess in the United States beginning on February 1, 203...

Allergan to Pay $3.5 Million for FCA Claim Related to Defective LAP-BANDs

Allergan Inc. will pay $3.5 million to resolve allegations brought against it under the False Claims Act. The allegations surround Allergan’s LAP-BAND device, which is used by physicians to assi...

Pershing and Valeant Settle Allergan Lawsuits

Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two lawsuits related to t...

Drugs and Medications [336 Associated Drugs and Medications listed on BioPortfolio]

Refresh classic [Allergan, Inc.]

REFRESH Classic

Refresh liquigel [Allergan, Inc.]

REFRESH LIQUIGEL

Refresh celluvisc [Allergan, Inc.]

REFRESH CELLUVISCLubricant Eye Drops

Refresh plus [Allergan, Inc.]

REFRESH PLUSLubricant Eye Drops

Refresh optive sensitive [Allergan, Inc.]

REFRESH OPTIVE™ Sensitive

PubMed Articles [136 Associated PubMed Articles listed on BioPortfolio]

Allergan's Mohawk evergreening patent deal draws criticism, but ultimately may flop.

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [238 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1336 Associated Companies listed on BioPortfolio]

Allergan, Inc.

Allergan, Inc. is a multi-specialty health care company established 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful...

Allergan, Inc. and MAP Pharmaceuticals, Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Allergan Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Allergan Ligand Retinoid Therapeutics Inc

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company that develops and commercializes specialty pharmaceutical products for the eye care, neuromu...

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is focused on developing specialty CNS products designed to address unmet medical needs. The company’s portfolio is well diversified wit...

More Information about "Allergan, Inc. and MAP Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Allergan, Inc. and MAP Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Allergan, Inc. and MAP Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Allergan, Inc. and MAP Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergan, Inc. and MAP Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Allergan, Inc. and MAP Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...


Corporate Database Quicklinks



Searches Linking to this Company Record